» Articles » PMID: 38474346

Adenosine in Intestinal Epithelial Barrier Function

Overview
Journal Cells
Publisher MDPI
Date 2024 Mar 13
PMID 38474346
Authors
Affiliations
Soon will be listed here.
Abstract

At the intestinal front, several lines of defense are in place to resist infection and injury, the mucus layer, gut microbiome and strong epithelial junctions, to name a few. Their collaboration creates a resilient barrier. In intestinal disorders, such as inflammatory bowel disease (IBD), barrier function is compromised, which results in rampant inflammation and tissue injury. In response to the destruction, the intestinal epithelium releases adenosine, a small but powerful nucleoside that functions as an alarm signal. Amidst the chaos of inflammation, adenosine aims to restore order. Within the scope of its effects is the ability to regulate intestinal epithelial barrier integrity. This review aims to define the contributions of adenosine to mucus production, microbiome-dependent barrier protection, tight junction dynamics, chloride secretion and acid-base balance to reinforce its importance in the intestinal epithelial barrier.

Citing Articles

Purinergic agonists increase [Ca] in rat conjunctival goblet cells through ryanodine receptor type 3.

Fjaervoll H, Fjaervoll K, Yang M, Reiten O, Bair J, Lee C Am J Physiol Cell Physiol. 2024; 327(3):C830-C843.

PMID: 39099424 PMC: 11427011. DOI: 10.1152/ajpcell.00291.2024.


Human gut microbiota-reactive DP8α Tregs prevent acute graft-versus-host disease in a CD73-dependent manner.

Godefroy E, Chevallier P, Haspot F, Vignes C, Daguin V, Lambot S JCI Insight. 2024; 9(18).

PMID: 39088302 PMC: 11457850. DOI: 10.1172/jci.insight.179458.


The Use of Polysaccharide AOP30 from the Rhizome of Hance to Alleviate Lipopolysaccharide-Induced Intestinal Epithelial Barrier Dysfunction and Inflammation via the TLR4/NfκB Signaling Pathway in Caco-2 Cell Monolayers.

Jia X, Huang Y, Liu G, Li Z, Tan Q, Zhong S Nutrients. 2024; 16(13).

PMID: 38999898 PMC: 11243348. DOI: 10.3390/nu16132151.

References
1.
Schlegel N, Boerner K, Waschke J . Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients. Acta Physiol (Oxf). 2020; 231(1):e13492. DOI: 10.1111/apha.13492. View

2.
Ding X, Li D, Li M, Tian D, Yu H, Yu Q . Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation. Int J Mol Med. 2017; 41(3):1224-1232. PMC: 5819926. DOI: 10.3892/ijmm.2017.3347. View

3.
Welihinda A, Kaur M, Greene K, Zhai Y, Amento E . The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias. Cell Signal. 2016; 28(6):552-60. PMC: 4826793. DOI: 10.1016/j.cellsig.2016.02.010. View

4.
Li M, Liu B, Li R, Yang P, Leng P, Huang Y . Exploration of the link between gut microbiota and purinergic signalling. Purinergic Signal. 2022; 19(1):315-327. PMC: 9984663. DOI: 10.1007/s11302-022-09891-1. View

5.
Fredholm B, Irenius E, Kull B, Schulte G . Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol. 2001; 61(4):443-8. DOI: 10.1016/s0006-2952(00)00570-0. View